Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Melanoma/Skin Cancer
•
Dermatology
What dosing range do you typically use for treating SCC in situ on the trunk and extremities with methotrexate?
Related Questions
How do you approach patients with early stage resected melanoma (Stage IIA) for adjuvant treatment?
Is narrow-band ultraviolet B (nbUVB) phototherapy contraindicated or recommended with caution in patients with a personal history of melanoma?
Would you offer adjuvant immunotherapy in an elderly patient with stage IIB desmoplastic melanoma post resection with underlying autoimmune disease?
How would you approach a recurrent, cutaneous SCC of the face with high-risk features s/p resection?
What histologic findings most commonly lead you to order additional staining for potential desmoplastic melanoma?
What is your treatment algorithm for actinic cheilitis?
How would you treat a periungual squamous cell carcinoma of the thumb?
How do you approach patients with very low risk stage IIIA cutaneous melanoma for adjuvant immunotherapy?
What therapies do you most commonly recommend for prevention of NMSC in organ transplant patients?
How would you approach patients receiving neoadjuvant pembrolizumab (SWOG 1801) for melanoma with no response to systemic treatment?
